Result:Good· Market: UpMargin expansionCost led
| Metric | Value | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 221.61 Cr | 5.2% | 11.0% |
| Total Income | 223.98 Cr | 4.5% | 10.8% |
| Expenditure | 203.75 Cr | 4.0% | 7.1% |
| PBT | 20.23 Cr | 10.4% | 70.1% |
| Net Profit | 14.95 Cr | 7.8% | 67.5% |
| OPM | 9.92% | 0.90pp | 3.17pp |
| NPM | 6.68% | 0.21pp | 2.27pp |
| EPS | 5.75 | 7.9% | 67.6% |
Chemicals: revenue grew a healthy 11% YoY while OPM expanded sharply (6.75%→9.92%), driving 67.5% adjusted PAT growth led by core margin gains rather than one-offs — strong but not a standout since top-line growth itself was only moderate.
Informational and educational content only. Not investment advice.